PharmaCyte Biotech Files Q3 10-Q

Ticker: PMCB · Form: 10-Q · Filed: Mar 17, 2025 · CIK: 1157075

Pharmacyte Biotech, Inc. 10-Q Filing Summary
FieldDetail
CompanyPharmacyte Biotech, Inc. (PMCB)
Form Type10-Q
Filed DateMar 17, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, biotech, financials

Related Tickers: PMCB

TL;DR

PharmaCyte Biotech (NASDAQ: PMCB) filed their 10-Q for Jan 2025. Check financials.

AI Summary

PharmaCyte Biotech, Inc. filed its 10-Q for the period ending January 31, 2025. The company, previously known as NuVilex, Inc., is in the biological products sector and is incorporated in Nevada. Their business address is in Laguna Hills, California.

Why It Matters

This filing provides investors with an update on PharmaCyte Biotech's financial performance and operational status for the third quarter of their fiscal year.

Risk Assessment

Risk Level: medium — As a biotech company, PharmaCyte Biotech faces inherent risks related to drug development, regulatory approvals, and market competition.

Key Numbers

  • 2025-01-31 — Fiscal Quarter End (Reporting period for the 10-Q)
  • 2025-03-17 — Filing Date (Date the 10-Q was submitted)

Key Players & Entities

  • PharmaCyte Biotech, Inc. (company) — Filer of the 10-Q
  • 20250131 (date) — End of reporting period
  • 20250317 (date) — Filing date
  • Laguna Hills, CA (location) — Business and mailing address
  • NuVilex, Inc. (company) — Former company name

FAQ

What is PharmaCyte Biotech's primary business?

PharmaCyte Biotech is primarily involved in the biological products sector, specifically biological products (no diagnostic substances).

When does PharmaCyte Biotech's fiscal year end?

PharmaCyte Biotech's fiscal year ends on April 30th.

What was the previous name of PharmaCyte Biotech?

The company was formerly known as NuVilex, Inc., with a name change on March 24, 2009.

Where is PharmaCyte Biotech located?

The company's business and mailing address is 23046 Avenida de la Carlota, Suite 600, Laguna Hills, CA 92653.

What is the SEC file number for PharmaCyte Biotech?

The SEC file number for PharmaCyte Biotech is 001-40699.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on March 17, 2025 regarding PharmaCyte Biotech, Inc. (PMCB).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.